-
Axogen Announces First Surgical Implants of Avive+ Soft Tissue Matrix™
29 Apr 2024 20:50 GMT
… critical phase of tissue repair; Axoguard Nerve Connector®, a porcine submucosa extracellular matrix …
-
Axogen, Inc. to Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024
16 Apr 2024 11:00 GMT
… critical phase of tissue repair; Axoguard Nerve Connector®, a porcine submucosa extracellular matrix …
-
Axogen, Inc Reports 2023 Fourth Quarter and Full-Year Financial Results
05 Mar 2024 12:00 GMT
… with a second surgical site; Axoguard Nerve Connector®, a porcine submucosa ECM coaptation …
-
Axogen, Inc. to Report 2023 Fourth Quarter and Full-Year Financial Results on March 5, 2024
13 Feb 2024 21:30 GMT
… with a second surgical site; Axoguard Nerve Connector®, a porcine submucosa ECM coaptation …
-
Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
02 Feb 2024 21:15 GMT
… with a second surgical site; Axoguard Nerve Connector®, a porcine submucosa ECM coaptation …
-
SG Americas Securities LLC Acquires New Holdings in AxoGen, Inc. (NASDAQ:AXGN)
22 Jan 2024 11:31 GMT
… with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix …
-
AxoGen (NASDAQ:AXGN) Rating Reiterated by Cantor Fitzgerald
21 Jan 2024 08:18 GMT
… with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix …
-
Axogen, Inc. Announces Positive Topline Results from REPOSE, a Prospective, Randomized Clinical Trial of Axoguard Nerve Cap
18 Jan 2024 22:00 GMT
… with a second surgical site; Axoguard Nerve Connector®, a porcine submucosa ECM coaptation …
-
AxoGen, Inc. (NASDAQ:AXGN) Short Interest Up 7.1% in December
17 Jan 2024 15:55 GMT
… with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix …
-
StockNews.com Lowers AxoGen (NASDAQ:AXGN) to Hold
09 Jan 2024 09:02 GMT
… with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix …